GSK plc GSK
NYSE GSK
$47.83 -0.75 (-1.54%)
At close: Nov 19, 2026 · 4:00 PM EST

Gsk (GSK) Other Non Operating Income (2026)

Updated

Gsk (GSK) reported Other Non Operating Income of -$162.34 million for the quarter ended Jun 30, 2026.

Analysis

Gsk (GSK) Other Non Operating Income (2026) Analysis & Trends

For the year ended Dec 31, 2023, Gsk posted Other Non Operating Income of $19.9 million, up 129.7% from the prior year.

  • By year, Other Non Operating Income came in at $8.66 million in the year ended Dec 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn
9 Gsk 193.54 Bn 176.38 Bn -
10 Pfizer 156.44 Bn 103.79 Bn 12.56 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -162.34 Mn
API Access

Gsk Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=GSK&period=max&api_key=YOUR_API_KEY